Literature DB >> 16989928

The sexuality and social performance of androgen-deprived (castrated) men throughout history: implications for modern day cancer patients.

Michael William Aucoin1, Richard Joel Wassersug.   

Abstract

Androgen-deprivation therapy (ADT) via either surgical or chemical castration is the standard treatment for advanced prostate cancer (PCa). In North America, it is estimated that more than 40,000 men start ADT each year. The side effects of this treatment are extensive and include gynecomastia, erectile dysfunction, and reduced libido. These changes strongly challenge patients' self-identity and sexuality. The historical term for a man who has been castrated is 'eunuch', now a pejorative term implying overall social and sexual impotence. In this paper, we review key historical features of eunuch social performance and sexuality from a variety of cultures in order to assess the validity of contemporary stereotypes of the androgen-deprived male. Data were taken from secondary sources on the history of Byzantium, Roman Antiquity, Early Islamic societies, the Ottoman Empire, Chinese Dynasties, and the Italian Castrati period. This cross-cultural survey shows that castrated men consistently held powerful social positions that yielded great political influence. Many eunuchs were recognized for their loyalty, managerial style, wisdom, and pedagogical skills. Furthermore, rather than being consistently asexual and celibate, they were often sexually active. In certain cultures, they were objects of sexual desire for males, or females, or both. Collectively, the historical accounts suggest that, given the right cultural setting and individual motivation, androgen deprivation may actually enhance rather than hinder both social and sexual performance. We conclude that eunuch history contradicts the presumption that androgen deprivation necessarily leads to social and sexual impotence. The capabilities and accomplishments of eunuchs in the past gives patients on ADT grounds for viewing themselves in a positive light, where they are neither socially impotent nor sexually chaste.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16989928     DOI: 10.1016/j.socscimed.2006.08.007

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

1.  Passing through the wall: on outings, exodus, angels, and the ark.

Authors:  Richard Joel Wassersug
Journal:  J Relig Health       Date:  2008-12-30

2.  Impact of androgen deprivation therapy on sexual function: a response.

Authors:  Erik Wibowo; Richard Wassersug; Karen Warkentin; Lauren Walker; John Robinson; Lori Brotto; Thomas Johnson
Journal:  Asian J Androl       Date:  2012-07-16       Impact factor: 3.285

3.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

Review 4.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

Review 5.  Evolution of sexually dimorphic longevity in humans.

Authors:  David Gems
Journal:  Aging (Albany NY)       Date:  2014-02       Impact factor: 5.682

6.  Voluntary genital ablations: contrasting the cutters and their clients.

Authors:  Robyn A Jackowich; Rachel Vale; Kayla Vale; Richard J Wassersug; Thomas W Johnson
Journal:  Sex Med       Date:  2014-08       Impact factor: 2.491

7.  Gender Preference in the Sexual Attractions, Fantasies, and Relationships of Voluntarily Castrated Men.

Authors:  Ariel B Handy; Robyn A Jackowich; Erik Wibowo; Thomas Wayne Johnson; Richard J Wassersug
Journal:  Sex Med       Date:  2016-03       Impact factor: 2.491

Review 8.  Co-constructing sexual recovery after prostate cancer: a qualitative study with couples.

Authors:  Daniel Kelly; Liz Forbat; Sylvie Marshall-Lucette; Isabel White
Journal:  Transl Androl Urol       Date:  2015-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.